A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities
Key facts
- Who runs it
- University of Minnesota
- Where
- Minneapolis and Rochester, United StatesSee the 3 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 700 people enrolled
- Started
- 5 May 2023
- Expected to end
- 31 Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Longitudinal Proactive Outreach (LPO).
- Ask-Advice-Connect (AAC)
- Record updated
- 13 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- English or Spanish-speaking BIPOC patients within the Hennepin Healthcare or MCHS system. BIPOC patients are any patients with a chart identified race that is not White, and will be verified by self-report from the baseline survey
- Currently smoke >1 cigarette over the past 30 days
- Must have address or telephone number in the electronic health record
Who cannot take part
- Electronic health record documented cognitive impairment or legal guardianship
- Patients who have opted out of reserach studies
Where in United States
- Hennepin HealthcareMinneapolis, United States
- University of MinnesotaMinneapolis, United States
- Mayo Clinic Health SystemRochester, United States
About the trial
What the trial wants to find out
This project will evaluate a proactive outreach intervention for tobacco cessation among primary care BIPOC populations who smoke in two health systems across the region. Compared with Whites, BIPOC populations in the US experience disproportionate health consequences from commercial cigarette use. Few evidence-based cessation treatments (EBCTs) have been specifically developed, evaluated, or implemented for BIPOC populations. Moreover, uptake of EBCT (e.g. medication, counseling) is lower among BIPOC populations. Reasons for the failure to engage BIPOC patients in EBCTs are complex and multi-level (e.g., patient, provider, healthcare system). To address these gaps, the investigators will assess the added effectiveness of an approach to augment the standard of care with longitudinal proactive outreach to connect BIPOC adults with EBCT. The proposed multi-level intervention leverages the electronic health record to identify patients who smoke, who can then be proactively engaged via culturally tailored outreach to connect them to EBCT. The proactive approach may circumvent experiences of bias within the healthcare system and thus enhance engagement.
The 2 groups in the trial
- Enhanced Usual Care: Ask-Advice-Connect (AAC)Existing treatment, for comparison
AAC participants will receive care through their primary care provider as usual (with the caveat that providers in the clinics will be trained to provide AAC). AAC includes enhanced access to State Quitline and Nicotine Replacement Therapy.
Treatment: Ask-Advice-Connect (AAC)
- AAC + Longitudinal Proactive Outreach (LPO)Treatment being tested
AAC+LPO participants will receive AAC plus an MI tailored outreach call at baseline and at 3, 6, and 9 months post-enrollment. AAC includes enhanced access to State Quitline and Nicotine Replacement Therapy.
Treatment: Longitudinal Proactive Outreach (LPO). and Ask-Advice-Connect (AAC)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Evaluating chronic disease approaches to ameliorate tobacco-related health disparities: Study protocol of a hybrid type 1 implementation-effectiveness trial.Contemporary clinical trials communications, 2024
- Record updated
- 13 April 2026